16 year old Paudie Coady has Friedrich’s Ataxia, a rare,
degenerative neurological condition. Last year, the same
condition claimed the life of his younger brother Rory.
The boys’ mother, Della, has advanced Huntington’s disease.
Their dad Craig is in a race against time. Yesterday, he met
Taoiseach Micheál Martin as part of his campaign for the HSE to
introduce the drug Skyclarys in Ireland.
Skyclarys would slow down the progression of Paudie’s illness and
give him a better quality of life.
Joining Deirdre on today’s episode, Craig said the system for
approving new drugs in Ireland is not working.
“Look at the silly money the HSE are spending on mistakes in
hospitals. You know, you have someone up there that's going
around high fiving, yeah, I saved €500,000 here, I saved €1.2
million here, I saved this here, but yeah, how many lives have
you saved?
“If there's a price tag on every child in this country, well,
it's a sorry country,” he said.
“Do you want to go to bed every night thinking, God, I hope my
child doesn't really get sick because there's no hope?
After meeting Taoiseach Micheál Martin – whom he describes as “a
family man”, who was emotional during their meeting – Craig is
hopeful that there will be progress on Skyclarys.
“He had a representative down from Dublin, a HSE / Department of
Health representative, and he said it is on the agenda for
July... He said that they were trying to push that meeting
forward and he was hoping that it would happen.
“He understands that Friedrich’s Ataxia doesn’t wait.”
Craig joins Deirdre O’Shaughnessy on today’s podcast to talk
about his meeting with Taoiseach Micheál Martin, losing Rory, and
the tragedy of his wife Della’s Huntington’s Disease.
Taoiseach tells Cork dad who lost one son that discussions on
life-changing drug for his other son will be brought forward
'I can’t lose him. He is all I have left': Cork father 'begging'
for drug for disease affecting son
Niamh Ní Hoireabhaird: How much is my life worth to the HSE?
Hosted on Acast. See acast.com/privacy for more information.
Kommentare (0)
Melde dich an, um einen Kommentar zu schreiben.